Author:
Purdie C A,Quinlan P,Jordan L B,Ashfield A,Ogston S,Dewar J A,Thompson A M
Publisher
Springer Science and Business Media LLC
Reference46 articles.
1. Arpino G, Weiss H, Lee A, Schiff R, De Placido S, Osborne C, Elledge R (2005) Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance. J Natl Cancer Inst 97: 1254–1261.
2. Bardou V-J, Arpino G, Elledge RM, Osborne CK, Clark GM (2003) Progesterone receptor status significantly improves outcome prediction over estrogen receptor status alone for adjuvant endocrine therapy in two large breast cancer databases. J Clin Oncol 21: 1973–1979.
3. Blamey R, Davies C, Elston C, Johnson J, Haybittle J, Maynard P (1979) Prognostic factors in breast cancer – the formation of a prognostic index. Clin Oncol 5: 227–236.
4. Breast International Group (BIG) 1-98 Collaborative Group, Thürlimann B, Keshaviah A, Coates AS, Mouridsen H, Mauriac L, Forbes JF, Paridaens R, Castiglione-Gertsch M, Gelber RD, Rabaglio M, Smith I, Wardley A, Wardly A, Price KN, Goldhirsch A (2005) A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer. N Engl J Med 353: 2747–2757.
5. BSP (2005) Pathology Reporting of Breast Disease. NHS BSP: Sheffield. 1–144, Publication No 58.
Cited by
136 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献